Diagnosis and treatment of Parkinson disease: a review
MJ Armstrong, MS Okun - Jama, 2020 - jamanetwork.com
Importance Parkinson disease is the most common form of parkinsonism, a group of
neurological disorders with Parkinson disease–like movement problems such as rigidity …
neurological disorders with Parkinson disease–like movement problems such as rigidity …
Axes of a revolution: challenges and promises of big data in healthcare
Health data are increasingly being generated at a massive scale, at various levels of
phenotyping and from different types of resources. Concurrent with recent technological …
phenotyping and from different types of resources. Concurrent with recent technological …
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
Several studies have confirmed the α-synuclein real-time quaking-induced conversion (RT-
QuIC) assay to have high sensitivity and specificity for Parkinson's disease. However …
QuIC) assay to have high sensitivity and specificity for Parkinson's disease. However …
Statistical power for cluster analysis
Background Cluster algorithms are gaining in popularity in biomedical research due to their
compelling ability to identify discrete subgroups in data, and their increasing accessibility in …
compelling ability to identify discrete subgroups in data, and their increasing accessibility in …
Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease
E De Pablo-Fernández, AJ Lees, JL Holton… - JAMA …, 2019 - jamanetwork.com
Importance Clinical subtyping of Parkinson disease at diagnosis is useful in estimating
disease course and survival. Severity and rate of progression of neuropathologies are …
disease course and survival. Severity and rate of progression of neuropathologies are …
Genome‐wide association studies of cognitive and motor progression in Parkinson's disease
Background There are currently no treatments that stop or slow the progression of
Parkinson's disease (PD). Case–control genome‐wide association studies have identified …
Parkinson's disease (PD). Case–control genome‐wide association studies have identified …
The clinical heterogeneity of Parkinson's disease and its therapeutic implications
JC Greenland, CH Williams‐Gray… - European Journal of …, 2019 - Wiley Online Library
Although Parkinson's disease (PD) is primarily a movement disorder, there are a range of
associated nonmotor symptoms, including cognitive impairment, depression and sleep …
associated nonmotor symptoms, including cognitive impairment, depression and sleep …
Brain iron deposition is linked with cognitive severity in Parkinson's disease
GEC Thomas, LA Leyland, AE Schrag… - Journal of Neurology …, 2020 - jnnp.bmj.com
Background Dementia is common in Parkinson's disease (PD) but measures that track
cognitive change in PD are lacking. Brain tissue iron accumulates with age and co-localises …
cognitive change in PD are lacking. Brain tissue iron accumulates with age and co-localises …
Sleep disturbance as potential risk and progression factor for Parkinson's disease
Sleep disturbances are common and a major source of disability in Parkinson's disease
(PD). Primary and secondary insomnia, rapid eye movement sleep behavior disorder (RDB) …
(PD). Primary and secondary insomnia, rapid eye movement sleep behavior disorder (RDB) …
Parkinson's disease subtypes: critical appraisal and recommendations
TA Mestre, SM Fereshtehnejad, D Berg… - Journal of …, 2021 - content.iospress.com
Background: In Parkinson's disease (PD), there is heterogeneity in the clinical presentation
and underlying biology. Research on PD subtypes aims to understand this heterogeneity …
and underlying biology. Research on PD subtypes aims to understand this heterogeneity …